Recombinant Anti-Human A human cancer antigen Antibody (Fc glycosylation) (CAT#: Gly-079LC)

This product is a humanized monoclonal antibody with N-glycosylation site in the Fc region. The antibody NRX451 with enhanced ADCC specifically binds 40 kilodalton glycoprotein antigen expressed on a large array of carcinomas and can be potentially used in the treatment of cancer.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Datasheet
  • MSDS
  • COA

Glyco-engineering

  • Glycosylation site
  • Fc region
  • Glycosylation Type
  • N-glycosylation
  • Activity
  • Enhanced ADCC

Specifications

  • Target
  • a human cancer antigen
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Clone
  • NRX451
  • Applications
  • ELISA

Target

  • Alternative Names
  • a human cancer antigen
  • Related Disease
  • Cancer

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for Gly-079LC. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare